Hep B Press Releases
The Hepatitis B Foundation is happy to assist the media in reporting on the impact of hepatitis B worldwide. We can coordinate interviews with experts in research, public health, community outreach efforts and immunization and treatment initiatives.
Media contact: Ed Tate, director of communications and marketing, email@example.com, 267-934-3475
Hepatitis B Foundation launches first global registry of discrimination against people living with hepatitis B
Doylestown, Pa., May 13, 2021 – People globally who are living with hepatitis B often experience discrimination in variety of ways, including denial of access to employment and education, even in the U.S., and an American nonprofit organization has launched the world’s first initiative to track and analyze that discrimination. Please read more here.
Hepatitis B Foundation supports launch of new global online forum dedicated to supporting people with hepatitis B, connecting with health experts
April 13, 2021 – The Hepatitis B Foundation is pleased to support the official launch of HepBcommunity.org, a new global online forum dedicated to supporting those living with and affected by hepatitis B. Please read more here.
Hepatitis B Foundation to hold its annual Crystal Ball Gala on April 30
April 8, 2021 – Our annual Crystal Ball Gala later this month holds a special significance: it is the ceremonial start of the Foundation's 30th Anniversary celebration. Please read more here.
Hepatitis B Foundation mourns the passing of John C. Martin, pharmaceutical industry leader
April 1, 2021 - The leadership and staff of the Hepatitis B Foundation share a high regard for John C. Martin, PhD, former CEO of Gilead Sciences Inc., who died suddenly this week. Please read more here.
Chronic hepatitis B is far more prevalent among U.S. residents than previously reported
March 10, 2021 – The number of adults living in the U.S. who have chronic hepatitis B infection may be as high as 2.4 million, which is nearly three times greater than the federal government’s official estimate, according to a new analysis by a team of public health experts, scientists and physicians. Please read more here.
Hepatitis B Foundation mourns loss of co-founder Paul Witte
Feb. 15, 2021 The Hepatitis B Foundation announces with great sadness the passing of Mr. Paul Witte, 94. An award-winning industrial and product-design engineer, Paul never hesitated to share his talents and resources to help create the Foundation as an important advisor and generous philanthropist. Please read more here.
All of Us research program
Feb. 15, 2021 – From 2020-2021, the proportion of Asian American and Pacific Islander communities represented in biomedical research has doubled, growing from 2% to 4%. The All of Us Research Program wants to encourage this valuable trend going. Please read more here.
Hepatitis B Foundation launches continuing education series on hepatitis B for health care providers and public health professionals
Feb. 5, 2021 – The Hepatitis B Foundation has launched Hep B Project ECHO Philadelphia, a continuing education series for health care providers and public health professionals using the ECHO Model™ to deliver educational content about hepatitis B to physicians, nurses, pharmacists, public health coordinators and other health care professionals. Please read more here.
Hepatitis B Foundation applauds release of National Hepatitis Strategic Plan
Jan. 7, 2021 – Today the U.S. Department of Health and Human Services (HHS) released the Viral Hepatitis National Strategic Plan, which provides a roadmap toward the elimination of viral hepatitis in the U.S. (2021-2025), including key objectives and strategies to eliminate hepatitis B and related health inequities. Please read more here.
Bristol Myers Squibb provides grant for work to reduce disparities in liver cancer for high-risk minority groups in the U.S.
Dec. 22, 2020 – Bristol Myers Squibb has awarded a one-year, $134,000 grant to the Hepatitis B Foundation to close the disparity gaps related to hepatitis B-associated liver cancer in the United States among Asian Americans, Pacific Islanders, African immigrant communities and other high-risk groups. Please read more here.
Federal Task Force Recommendation for Hepatitis B Screening Fails to Close Gaps in Diagnosis Rates
Dec. 16, 2020 – The Hepatitis B Foundation today released the following statement regarding the recent publication of a new statement from the U.S. Preventive Services Task Force (USPSTF). Please read more here.
Hepatitis B community leaders convene to address eliminating hepatitis B during COVID-19 pandemic
Nov. 30, 2020 – Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, will host its eighth annual (and first virtual) summit Dec. 2-4. Please read more here.
Hep B United to honor Corinna Dan, former HHS official
Hep B United and the HBV Forum are pleased to name Corinna Dan, RN, MPH, as the 2020 recipient of the Hepatitis B Federal Champion Award for her commitment to eliminating hepatitis B. Ms. Dan will receive the award at the Hep B United Virtual Summit on Dec. 4. Please read more here.
Hepatitis B Foundation announces 2021 Baruch S. Blumberg Prize
Nov. 12, 2020 -- The Hepatitis B Foundation is announcing today (Nov. 12) that Wenhui Li, Ph.D., has been chosen as the recipient of its 2021 Baruch S. Blumberg Prize for outstanding contributions to advance the science and medicine of hepatitis B. Please read more here.
Hepatitis B Foundation applaud HHS letter on discrimination against people living with hepatitis B pursing careers in health care
Nov. 6, 2020 - The Hepatitis B Foundation applauds the U.S. Department of Health and Human Services (HHS) for issuing a letter to health professions schools in the U.S., calling for renewed attention to admissions and clinical placement policies and their obligation to comply with federal civil rights laws that protect the rights of people living with hepatitis B. Please read more here.
Major new award to be presented to our co-founders Joan and Timothy Block
Nov. 4, 2020 - Hepatitis B Foundation co-founders Joan Block, R.N., and Timothy M. Block, Ph.D., will be receiving a very significant honor in November during The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. The Association recently announced that, during the Nov. 13-16 Liver Meeting Digital Experience, the Blocks will receive the inaugural Distinguished Advocacy Service Award. Please read more here.
Hepatitis B Foundation launches new tool to assist people living with hepatitis B in making decisions on health insurance
Oct. 29, 2020 - The Hepatitis B Foundation today released a new report, Health Insurance Costs Impacting Shoppers Living with Hepatitis B, that is designed to help those living with chronic hepatitis B and their caregivers make better-informed decisions when choosing health insurance plans. Please read more here.
Hepatitis B Foundation releases report on first-ever Externally Led Patient-Focused Drug Development meeting for hepatitis B
Oct. 27, 2020 - In cooperation with the U.S. Food and Drug Administration (FDA), the Hepatitis B Foundation hosted an Externally Led Patient-Focused Drug Development (PFDD) meeting focused on hepatitis B on June 9, 2020. Today, the Foundation released its comprehensive report on the information-gathering event. Please read more here.
Hepatitis B Foundation launches B the Voice Story Bank
Aug. 18, 2020 – The Hepatitis B Foundation today is launching its new B the Voice Story Bank, an initiative to gather the stories of people around the world affected by hepatitis B. Please read more here.
Hepatitis B Foundation expresses appreciation for the work of Dr. Ding-Shinn Chen with the announcement of his death
June 25, 2020 - The Hepatitis B Foundation today is expressing its profound sadness at the passing of Dr. Ding-Shinn Chen, distinguished professor of the National Taiwan University College of Medicine. Please read more here.
Hepatitis B Foundation and Hep B United Statement on the Federal Government’s Rollback of Critical Health Care Protections
June 16, 2020: The U.S. Department of Health and Human Services (HHS) finalized a rule last week to roll back critical nondiscrimination protections provided under Section 1557 of the Affordable Care Act (ACA). Please read more here.
Two Powerful Editorial Published by the Hepatitis B Foundation
May 30, 2020: Two Powerful Editorial Published by the Hepatitis B Foundation. Please read them here.
HBF to host first-ever online Externally Led Patient-Focused Drug Development meeting
May 28, 2020: In cooperation with the FDA, the Hepatitis B Foundation will host an online Externally Led Patient-Focused Drug Development meeting for those living with hepatitis B and other key stakeholders on June 9 from 12:30-4:30 p.m. EDT. Please read more here.
Leading the way to 2030
Rhea Racho named as a Health Hero!
May 15, 2020: Congratulations to Rhea Racho, Hepatitis B Foundation public policy and program manager, who has been named an AANHPI Health Hero by AAPCHO! Please read more here.
Hepatitis B Foundation Expands Hepatitis B Prevention Policy Initiatives
HHBV Vaccinations Save Lives, Reduce New Infections: National Adult Hepatitis B Vaccination Awareness Day
April 30, 2020: Only one quarter of U.S. adults ages 19 and older are fully vaccinated against hepatitis B, despite the availability of a safe and effective vaccine for more than 30 years. Today, on National Adult Hepatitis B Vaccination Awareness Day, we are calling for an increased commitment to improving adult hepatitis B vaccination coverage in the United States to reduce the number of new hepatitis B infections and hepatitis B-related deaths. Please read more here.
Hepatitis B Foundation Says "Thank You!" to its 100-plus Volunteers
April 22, 2020: During National Volunteer Week in the United States, the Hepatitis B Foundation is publicly thanking its more than 100 volunteers worldwide. Those dedicated individuals work with the Foundation to help serve people living with hepatitis B, their families and health care providers, sharing information about the resources available to them, particularly about the treatment and prevention of the infectious disease.Please read here.
Hepatitis B Foundation Announces Annual Fundraising Event to Go Virtual April 24
April 8, 2020: In this challenging time, the Hepatitis B Foundation continues to serve people living with hepatitis B, their families and health care providers, and planning continues for its principal annual fundraiser. The foundation is adapting its 2020 Crystal Ball Gala from an in-person event to our first “Pajama Gala.” Please read more here.
Hepatitis B Foundation, Baruch S. Blumberg Institute and Pennsylvania Biotechnology Center Announce New Director of Communications and Marketing
April 8, 2020: The Hepatitis B Foundation recently appointed Edward F. Tate III, a Newtown resident, as director of communications and marketing. Along with leading the foundation’s communications and marketing, Tate also will handle those functions for the Baruch S. Blumberg Institute and the Pennsylvania Biotechnology Center (PABC). Please read more here.
Hepatitis B Foundation Strongly Supports the Strategic Plan for Trans‐NIH Research to Cure Hepatitis B
Dec. 11, 2019: The National Institutes of Health (NIH) released a groundbreaking Strategic Plan for Trans‐NIH Research to Cure Hepatitis B on Dec. 10. This Plan is the first product from the NIH Hepatitis B Cure Strategic Plan Working Group that was created as a result of Fiscal Year 2019 Congressional Appropriations Report language advocated for by the Hepatitis B Foundation. Please read more here.
Hepatitis B Foundation Announces 2020 Baruch S. Blumberg Prize Winner
Nov. 18, 2019: The Hepatitis B Foundation has named John Taylor, PhD, the recipient of its 2020 Baruch S. Blumberg Prize for excellence in hepatitis B research. Dr. Taylor is a Professor Emeritus at Fox Chase Cancer Center in Philadelphia. Please read more.
Hepatitis B Foundation Plans Externally-Led Patient-Focused Drug Development Meeting for Chronic Hepatitis B in June 2020
Nov. 6, 2019: The Hepatitis B Foundation is pleased to have been approved by the U.S. Food and Drug Administration (FDA) to host an externally-led Patient-Focused Drug Development (PFDD) meeting on June 9, 2020 that will focus on chronic hepatitis B infection (CHB). Read more.
U.S. Falls Short in Reaching 2020 Goals for Hepatitis B
Sept. 18, 2019: The U.S. is falling short of targets for hepatitis B vaccination, and for reducing new hepatitis B cases, according to the 2019 National Viral Hepatitis Progress Report, released this week by the Centers for Disease Control and Prevention (CDC). Read more.
Hepatitis B Foundation Calls for Increased Resources for Hepatitis B Prevention in Response to CDC 2017 Surveillance Data Report
Sept. 11, 2019: The Hepatitis B Foundation is calling for increased resources to improve hepatitis B vaccination rates and educate high-risk communities, in response to newly-released viral hepatitis surveillance data from the Centers for Disease Control and Prevention (CDC). Read more.
Our Voices Made a Difference: CVS Caremark to Cover Vemlidy Prescriptions
Sept. 9, 2019: The Hepatitis B Foundation, along with our network of patients, providers and partners, has successfully advocated for improved access to the hepatitis B medication Vemlidy in the US. Read more.
Hepatitis B Foundation Commends New Rx Outreach Program to Provide Access to Affordable Hepatitis B Medication
The Hepatitis B Foundation commends Rx Outreach, a nonprofit online pharmacy, for expanding their service to provide medications to help more than 2 million Americans who are chronically infected with hepatitis B. Read more.
Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2019
The Hepatitis B Foundation (HBF) strongly endorses yesterday’s re-introduction of the Liver Illness Visibility, Education and Research (LIVER) Act of 2019 (HR 3016). Read more.
2018 Press Releases
Hepatitis B Foundation Announces 2019 Baruch S. Blumberg Prize Winner
The Hepatitis B Foundation has named Christoph Seeger, PhD, the recipient of its 2019 Baruch S. Blumberg Prize for excellence in hepatitis B research. Dr. Seeger will receive his award at the 2019 Crystal Ball Gala on April 26, 2019. Read more.
Hep B United Applauds Bipartisan Legislation to Combat Opioid Crisis and Opioid Related Infectious Diseases
Hep B United today released the following statement, commending Congress for working together to pass the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act. The legislation was signed into law by the president, following overwhelming bipartisan Congressional support. Read more
Hepatitis B Foundation Endorses the Liver Illness Visibility, Education, and Research (LIVER) Act of 2018
The Hepatitis B Foundation (HBF) strongly endorses the introduction the Liver Illness Visibility, Education and Research (LIVER) Act of 2018. Introduced by Representative Nydia Velazquez (D-NY), the bill takes bold steps to increase investments in research, prevention, and awareness activities to address hepatitis B. Read more.
Hepatitis B Foundation Calls for Universal Screening for Hepatitis B
In recognition of World Hepatitis Day on July 28, the Hepatitis B Foundation (HBF) is calling for all Americans to be tested for hepatitis B infection. The formal recommendation was approved by HBF’s Scientific and Medical Advisory Board to achieve the World Health Organization’s (WHO) ambitious goal of eliminating hepatitis B by the year 2030. Read more.
Hepatitis B Leaders Call for the Elimination of Hepatitis B
Hep B United, a national coalition established by the Hepatitis B Foundation (HBF) and the Association of Asian Pacific Community Health Organizations (AAPCHO) to address the silent epidemic of hepatitis B, hosts its sixth annual summit in Washington, D.C., July 24 to 26. The summit brings together community leaders, advocates and people with hepatitis B to promote screening and prevention strategies and advocate for equitable access to health care to further its mission to eliminate hepatitis B in the United States. Read more.
Hepatitis B Foundation Releases New #justB Stories to Empower People Affected by Hepatitis B, Raise Awareness and End Stigma
The Hepatitis B Foundation released seven new videos as part of its national #justB storytelling campaign, which was launched one year ago to highlight the personal stories of people from across the United States who have been affected by hepatitis B. Read more
Hepatitis B Foundation Honors Business Leader Fred Beans and Scientist Ding-Shinn Chen at its 2018 Crystal Ball Gala
The Hepatitis B Foundation (HBF) hosted over 230 leaders from academia, industry, government and the community at its annual Crystal Ball Gala on April 6, 2018 at Pinecrest Country Club in Lansdale, PA. Read more.
New Two-Dose HBV Vaccine Recommended by ACIP
February 22, 2018: The Advisory Committee on Immunization Practices’ (ACIP) voted today to unanimously recommend HEPLISAV-B™ for use among individuals age 18 years and older to prevent hepatitis B infection (HBV). The Hepatitis B Foundation welcomes the use of the new vaccine, which is expected to increase immunization rates for adults in the United States. Read more.
Timothy M. Block, PhD, President of Hepatitis B Foundation and its Baruch S. Blumberg Institute, named a 2017 National Academy of Inventors Fellow 2017
December 12, 2017: Timothy M. Block, Ph.D, has been named a Fellow of the US National Academy of Inventors (NAI), the organization announced Tuesday. Dr. Block is President of the Hepatitis B Foundation, as well as its research arm, the Baruch S. Blumberg Institute, and its Pennsylvania Biotechnology Center. Read more.
Hepatitis B Foundation Applauds FDA Approval of New Hepatitis B Vaccine
November 2017: Today on World Immunization Day, the Hepatitis B Foundation applauded the U.S. Food and Drug Administration’s (FDA) approval of HEPLISAV-B™, the first new hepatitis B vaccine in more than 25 years and the only two-dose schedule for the prevention of infection in adults. Read more.
CDC National Progress Report on Hepatitis Elimination Reveals Rise in Acute HBV Infections and Low Birth Dose Vaccination Rates in the U.S.
October 2017: The Hepatitis B Foundation statement on the CDC's national progress report on viral hepatitis elimination in the U.S., which measures progress toward 2020 goals. Read more.
Hepatitis B Foundation Announces Promotion of Chari Cohen, DrPH, MPH, to Vice President, Public Health and Programs
October 2017: The Hepatitis B Foundation, a national nonprofit organization headquartered in Doylestown, PA, has announced the promotion of Chari Cohen, DrPH, MPH to vice president, public health and programs. Read more.
Hepatitis B Foundation Mourns the Loss of Pioneering Hepatitis B Physician-Scientist Dr. W. Thomas London
June 2017: W. Thomas London, MD, an internationally renowned physician-scientist dedicated to the study of hepatitis B, passed away June 3 at the age of 85. Dr. London was a key member of the research team that discovered the hepatitis B virus in the early 1960s, and longtime member of the Board of the Hepatitis B Foundation and its research arm, the Baruch S. Blumberg Institute, where he also served as a distinguished scientific and medical advisor. Read more.
Hepatitis B Foundation Launches Hep B Cure Campaign for Increased NIH Funding
May 2017: The Hepatitis B Foundation launches its national Hep B Cure Campaign, which features a consensus research agenda that outlines top scientists’ priority research recommendations for hepatitis B and liver cancer. Read more.
Hepatitis B Foundation's #justB Campaign Gives Voice to Personal Stories During May Hepatitis Awareness Month
May 2017: The Hepatitis B Foundation has launched its innovative #justB Storytelling Campaign to highlight the personal stories of people affected by hepatitis B to capture public attention during May Hepatitis Awareness Month. Read more.
Hepatitis B Foundation Executive Director Retires After 25 Years of Service
April 2017: Co-founder Joan Block helped create the nation’s leading nonprofit research and disease advocacy organization dedicated to hepatitis B. Read more.
Hepatitis B Foundation Commends Targets to Eliminate Hepatitis B in U.S.
March 2017: The Hepatitis B Foundation commends the U.S. National Academies of Sciences, Engineering, and Medicine (NASEM) report, A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report, that concludes a 50 percent reduction in mortality from chronic hepatitis B infection, as well as elimination of mother-to-child transmission of hepatitis B, is possible in the United States by 2030with appropriate prioritization and resources. Read more.
Hepatitis B Foundation and HBV Forum Summary Report of Meeting with US FDA
March 2017: Representatives from the Hepatitis B Foundation and HBV Forum met with representatives from the US FDA to discuss clinical development of hepatitis B therapeutics. Read the meeting summary.
Fred Beans Family of Dealerships Donates $30,000 to Support the Hepatitis B Foundation's High School Enrichment Programs
February 2017: The Hepatitis B Foundation’s (HBF) High School Science Enrichment Program received a $30,000 donation from the Fred Beans Family of Dealerships to support its research program for outstanding high school students. Read more.
Hepatitis B Foundation Welcomes International Leaders to Its Scientific and Medical Advisory Board
February 2017: The Hepatitis B Foundation is pleased to announce that two internationally renowned experts in the area of viral hepatitis have joined its Scientific and Medical Advisory Board. Read more.
Hepatitis B Foundation Appoints Global Expert Dr. Nat Brown to Its Board of Directors
February 2017: The Hepatitis B Foundation, the nation’s leading nonprofit research and disease advocacy organization, is pleased to announce the appointment of Nathaniel Brown, M.D., a retired pharmaceutical executive living in San Francisco, to its Board of Directors. Read more.
Hepatitis B Foundation Launches #justB Storytelling Campaign
January 2017: The Hepatitis B Foundation unveils its #justB national storytelling campaign with real people sharing their stories about hepatitis B. The goal is to put a human face on this disease in order to increase public awareness, decrease stigma and discrimination, and to promote testing and treatment for hepatitis B, which will ultimately save lives. Read more.
World-Renowned Cancer Physician Scientist Dr. Richard G. Pestell Joins the Baruch S. Blumberg Institute
January 2017: World-renowned cancer physician scientist Richard G. Pestell, M.D., Ph.D., has joined the Baruch S. Blumberg Institute to serve as President of the Pennsylvania Cancer and Regenerative Medicine Research Center (PCARM). Read more.
Hepatitis B Research Pioneer Dr. Bud Tennant Leaves Behind a Distinguished Scientific Legacy
Nov. 2016: Bud C. Tennant, DVM, a pioneer in developing the woodchuck animal model for the study of hepatitis B, and distinguished member of the Hepatitis B Foundation’s Scientific and Medical Advisory Board, passed away on November 16. Read more.
Hepatitis B Foundation Co-Sponsors East Coast Film Premiere of Be About It
Nov. 2016: Documentary about two families profoundly affected by hepatitis B will show at Philadelphia Asian American Film Festival on November 20. Read more.
Hepatitis B Foundation Launches Nationwide Hepatitis Delta Virus (HDV) Campaign to Expand Awareness and Testing for HDV Infection
Oct. 2016: Collaboration with Eiger Biopharma and ARUP Laboratories Focuses on Deadly Form of Viral Hepatitis. Read more.
Living with Hepatitis B: Hepatitis B Foundation Launches Patient Storytelling Campaign
October 2016: National nonprofit creates program to help people living with hepatitis B share their stories. Read more.
Hepatitis B Foundation Applauds CMS Final Decision to Cover Hepatitis B Screening
September 2016: Hepatitis B screening test added as a preventive service for Medicare beneficiaries. Read more.
Hepatitis B Foundation Launches Comprehensive New Website to Celebrate 25th Anniversary
September 2016: National nonprofit’s new website offers improved user experience, simplified navigation as a trusted global authority for information about hepatitis B. Read more.
Baruch S. Blumberg Institute Congratulates Michael J. Sofia on Receiving the 2016 Lasker-DeBakey Clinical Medical Research Award
September 2016: Blumberg Institute professor receives celebrated scientific honor for his discovery of the cure for chronic hepatitis C infection. Read more.
Hepatitis B Foundation Partners with Eiger BioPharmaceuticals to Raise Awareness of Hepatitis Delta Virus Co-Infection
August 2016: Occurring only in those already infected with hepatitis B, hepatitis delta can lead to more severe liver disease than HBV alone. Read more.
‘Making the Link’ Between Viral Hepatitis and Liver Cancer
July 2016: Hepatitis B Foundation to urge Philadelphia city leaders to help decrease liver cancer rates by making chronic HBV and HCV testing and treatment a local priority. Read more.
Hepatitis B Foundation Marks 25th Anniversary at 2016 Crystal Ball Gala
April 2016: Annual event raises nearly $125,000 for research and outreach to eliminate hepatitis B that affects more than 12 million Americans and 2 billion people worldwide. Read more.
Hepatitis B Foundation’s ‘Nobel Challenge’ Raises $3 Million to Support Research for a Cure
Jan. 26 – The Hepatitis B Foundation announces the successful completion of its “Nobel Challenge” campaign, raising more than $3 million to recruit top scientists to its affiliated Baruch S. Blumberg Institute to fulfill its research mission - to find a cure for hepatitis B. Read more.
Baruch S. Blumberg Institute Partners with The Commonwealth Medical College to Offer Innovative Graduate Program
Jan. 14 - The Baruch S. Blumberg Institute, established by the Hepatitis B Foundation, announced today it will partner with The Commonwealth Medical College to offer the first life sciences graduate program in Bucks County, PA. Working professionals will be able to earn a Master's degree in Biological Sciences in 16 months during evening and weekend classes at the Blumberg Institute in Doylestown, PA. Read more.
Hepatitis B Foundation Leaders Help Shape National Plan to Eliminate Hepatitis B and C
Jan. 11, 2016 - Drs. Robert Gish and Chari Cohen of the Hepatitis B Foundation provide expert testimony to the National Academy of Medicine in support of a national strategy to eliminate chronic viral hepatitis in the United States by 2030. Read more.
Journal of the National Cancer Institute (JNCI) Publishes Summary of Hepatitis B Foundation’s Liver Cancer Workshop
Dec. 2015 - The JNCI paper submitted by the Hepatitis B Foundation in collaboration with thought leaders in the field focused on improving screening and care for those with liver cancer related to chronic hepatitis B infections. The article, “Hepatitis-Associated Liver Cancer: Gaps and Opportunities to Improve Care,” has been published online and will appear in the NCI Journal’s print issue in April 2016. Read more.
The W. Thomas London Distinguished Professorship Established by the Hepatitis B Foundation and Baruch S. Blumberg Institute
Oct. 2015 - The named Professorship honors Dr. W. Thomas London (on left) who made transformational contributions to the discovery of the hepatitis B virus with Dr. Baruch Blumberg and dedicated his career to the study of the virus and care of those affected. Dr. Ju Tao Guo (on right) is the inaugural recipient of the new professorship. He serves as director of Experimental Therapeutics at the Baruch S. Blumberg Institute, which was established by the Hepatitis B Foundation to fulfill its research mission. Read more.
2015 Press Releases
Dr. Eugene Schiff Receives Hepatitis B Foundation’s Highest Scientific Honor
April 20 – The 2015 Crystal Ball Gala, hosted by the Hepatitis B Foundation, was a huge success, and included an evening of dinner, dancing, live and silent auctions, a mission moment, and the awarding of the Baruch S. Blumberg Prize to Dr. Eugene Schiff for advancing the care and treatment of chronic hepatitis B. Read more.
Baruch S. Blumberg Institute Recruits World-Class Hepatitis B Scientists
March 2015 – The Baruch S. Blumberg Institute (www.blumberginstitute.org) has recruited a new team of nationally renowned scientists to focus exclusively on research to develop a cure for hepatitis B, a move that nearly triples its research capacity and has created the largest concentration of nonprofit scientists focusing solely on hepatitis B and liver cancer in the United States. Read more.
Hepatitis B Foundation Welcomes Two New Board Members
Jan 26 – The HBF is proud to announce that Craig Esterly, engineer and business owner, and Wayne Yetter, pharmaceutical industry executive, have joined its Board of Directors. Both bring broad and deep experience in the healthcare arena, and are joining the Foundation at a time when we are rapidly expanding and accelerating our pace of research into finding a cure for hepatitis B. Read more.